327 related articles for article (PubMed ID: 17374881)
1. Thematic review series: Adipocyte Biology. Lipodystrophies: windows on adipose biology and metabolism.
Hegele RA; Joy TR; Al-Attar SA; Rutt BK
J Lipid Res; 2007 Jul; 48(7):1433-44. PubMed ID: 17374881
[TBL] [Abstract][Full Text] [Related]
2. Lipodystrophies: disorders of adipose tissue biology.
Garg A; Agarwal AK
Biochim Biophys Acta; 2009 Jun; 1791(6):507-13. PubMed ID: 19162222
[TBL] [Abstract][Full Text] [Related]
3. Higher adiponectin levels in patients with Berardinelli-Seip congenital lipodystrophy due to seipin as compared with 1-acylglycerol-3-phosphate-o-acyltransferase-2 deficiency.
Antuna-Puente B; Boutet E; Vigouroux C; Lascols O; Slama L; Caron-Debarle M; Khallouf E; Lévy-Marchal C; Capeau J; Bastard JP; Magré J
J Clin Endocrinol Metab; 2010 Mar; 95(3):1463-8. PubMed ID: 20097706
[TBL] [Abstract][Full Text] [Related]
4. Exploring the pathophysiology behind the more common genetic and acquired lipodystrophies.
Nolis T
J Hum Genet; 2014 Jan; 59(1):16-23. PubMed ID: 24152769
[TBL] [Abstract][Full Text] [Related]
5. Human lipodystrophies: genetic and acquired diseases of adipose tissue.
Capeau J; Magré J; Caron-Debarle M; Lagathu C; Antoine B; Béréziat VR; Lascols O; Bastard JP; Vigouroux C
Endocr Dev; 2010; 19():1-20. PubMed ID: 20551664
[TBL] [Abstract][Full Text] [Related]
6. [Primary lipodystrophies].
Capeau J; Magré J; Lascols O; Caron M; Béréziat V; Vigouroux C
Ann Endocrinol (Paris); 2007 Feb; 68(1):10-20. PubMed ID: 17320032
[TBL] [Abstract][Full Text] [Related]
7. Lipodystrophies, dyslipidaemias and atherosclerotic cardiovascular disease.
Hussain I; Patni N; Garg A
Pathology; 2019 Feb; 51(2):202-212. PubMed ID: 30595509
[TBL] [Abstract][Full Text] [Related]
8. Diseases of adipose tissue: genetic and acquired lipodystrophies.
Capeau J; Magré J; Lascols O; Caron M; Béréziat V; Vigouroux C; Bastard JP
Biochem Soc Trans; 2005 Nov; 33(Pt 5):1073-7. PubMed ID: 16246048
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms of human lipodystrophies: from adipocyte lipid droplet to oxidative stress and lipotoxicity.
Vigouroux C; Caron-Debarle M; Le Dour C; Magré J; Capeau J
Int J Biochem Cell Biol; 2011 Jun; 43(6):862-76. PubMed ID: 21392585
[TBL] [Abstract][Full Text] [Related]
10. Lamin A/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophy.
Vigouroux C; Magré J; Vantyghem MC; Bourut C; Lascols O; Shackleton S; Lloyd DJ; Guerci B; Padova G; Valensi P; Grimaldi A; Piquemal R; Touraine P; Trembath RC; Capeau J
Diabetes; 2000 Nov; 49(11):1958-62. PubMed ID: 11078466
[TBL] [Abstract][Full Text] [Related]
11. Central players in inherited lipodystrophies.
Jeninga EH; Kalkhoven E
Trends Endocrinol Metab; 2010 Oct; 21(10):581-8. PubMed ID: 20621503
[TBL] [Abstract][Full Text] [Related]
12. Lipodystrophies.
Garg A
Am J Med; 2000 Feb; 108(2):143-52. PubMed ID: 11126308
[TBL] [Abstract][Full Text] [Related]
13. Quantitative and qualitative differences in subcutaneous adipose tissue stores across lipodystrophy types shown by magnetic resonance imaging.
Al-Attar SA; Pollex RL; Robinson JF; Miskie BA; Walcarius R; Little CH; Rutt BK; Hegele RA
BMC Med Imaging; 2007 Mar; 7():3. PubMed ID: 17352814
[TBL] [Abstract][Full Text] [Related]
14. How to diagnose a lipodystrophy syndrome.
Vantyghem MC; Balavoine AS; Douillard C; Defrance F; Dieudonne L; Mouton F; Lemaire C; Bertrand-Escouflaire N; Bourdelle-Hego MF; Devemy F; Evrard A; Gheerbrand D; Girardot C; Gumuche S; Hober C; Topolinski H; Lamblin B; Mycinski B; Ryndak A; Karrouz W; Duvivier E; Merlen E; Cortet C; Weill J; Lacroix D; Wémeau JL
Ann Endocrinol (Paris); 2012 Jun; 73(3):170-89. PubMed ID: 22748602
[TBL] [Abstract][Full Text] [Related]
15. Towards a mechanistic understanding of lipodystrophy and seipin functions.
Wee K; Yang W; Sugii S; Han W
Biosci Rep; 2014 Oct; 34(5):. PubMed ID: 25195639
[TBL] [Abstract][Full Text] [Related]
16. Adipose-specific knockout of SEIPIN/BSCL2 results in progressive lipodystrophy.
Liu L; Jiang Q; Wang X; Zhang Y; Lin RC; Lam SM; Shui G; Zhou L; Li P; Wang Y; Cui X; Gao M; Zhang L; Lv Y; Xu G; Liu G; Zhao D; Yang H
Diabetes; 2014 Jul; 63(7):2320-31. PubMed ID: 24622797
[TBL] [Abstract][Full Text] [Related]
17. Clinical and molecular aspects of Berardinelli-Seip Congenital Lipodystrophy (BSCL).
Gomes KB; Pardini VC; Fernandes AP
Clin Chim Acta; 2009 Apr; 402(1-2):1-6. PubMed ID: 19167372
[TBL] [Abstract][Full Text] [Related]
18. [Lipodystrophic syndromes: congenital or acquired diseases of adipose tissue].
Capeau J; Vigouroux C; Magré J; Lascols O; Caron M; Bastard JP
C R Biol; 2006 Aug; 329(8):639-52; discussion 653-5. PubMed ID: 16860281
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic heterogeneity in body fat distribution in patients with congenital generalized lipodystrophy caused by mutations in the AGPAT2 or seipin genes.
Simha V; Garg A
J Clin Endocrinol Metab; 2003 Nov; 88(11):5433-7. PubMed ID: 14602785
[TBL] [Abstract][Full Text] [Related]
20. The role of LMNA in adipose: a novel mouse model of lipodystrophy based on the Dunnigan-type familial partial lipodystrophy mutation.
Wojtanik KM; Edgemon K; Viswanadha S; Lindsey B; Haluzik M; Chen W; Poy G; Reitman M; Londos C
J Lipid Res; 2009 Jun; 50(6):1068-79. PubMed ID: 19201734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
